Liminal BioSciences  logo
Liminal BioSciences LMNL
$ 8.5 0.0%

Quarterly report 2022-Q2
added 08-10-2022

report update icon

Liminal BioSciences Financial Statements 2011-2024 | LMNL

Annual Financial Statements Liminal BioSciences

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

- 73.6 M 153 M 181 M 971 M 971 M 1.03 B 867 M 612 M 130 K -

Shares

30.2 M 16.1 M 16.1 M 828 K 684 K 598 K 571 K 578 K 490 K 420 K -

Historical Prices

0.88 4.8 8.25 299 1.1 K 1.8 K 1.95 K 1.98 K 1.4 K 457 113

Net Income

12.2 M -118 M -206 M -195 M -110 M -101 M -51 M 5.94 M -16.5 M 230 K -2.55 M

Revenue

643 K 3.32 M 4.9 M 24.6 M 39.1 M 16.4 M 24.5 M 23 M 20.6 M 23.3 M 17.6 M

Cost of Revenue

- - - - - - - - - - -

Gross Profit

- 1.28 M 2.14 M -1.07 M 29 M 9.63 M 16.3 M 16 M 14 M 18 M 15.7 M

Operating Income

- - - - - - - - - - -

Interest Expense

- - - - - - - - - - -

EBITDA

- -85.6 M -213 M -226 M -123 M -109 M -57.3 M -15.1 M -16.3 M 2 M -930 K

Operating Expenses

- 95.4 M 120 M 123 M 152 M 117 M 66.8 M 48.1 M 27.1 M 16.3 M 17.2 M

General and Administrative Expenses

- 38.6 M 45.3 M 29.4 M 51.9 M 29.3 M 16.6 M 12.1 M 8.58 M 5.97 M 5.79 M

All numbers in CAD currency

Quarterly Income Statement Liminal BioSciences

2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

- - - - - - 29.9 M - - - 23.4 M - - - 16.5 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Net Income

- - - - - - -32.1 M - - - -27.8 M - - - -134 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Revenue

- - - - - - - - - - 540 K - - - 762 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Interest Expense

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Expenses

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

General and Administrative Expenses

- - - - - - - - - - 9.85 M - - - 18 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in CAD currency